All SEC Filings :: Ligand Pharmaceuticals Incorporated (LGND)

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
11/03/22	4	Statement of changes in beneficial ownership of securities Related Documents EX-24			2
10/03/22	425	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions			7
10/03/22	8-K	Current report filing Related Documents EX-99.1			7
09/30/22	3	Initial statement of beneficial ownership of securities			1
09/30/22	8-K	Current report filing			4
09/30/22	S-3ASR	Automatic shelf registration statement of securities of well-known seasoned issuers Related Documents EX-1.2 EX-4.3 EX-5.1 EX-5.2 EX-23.1 EX-FILING FEES			137
09/22/22	4/A	Statement of changes in beneficial ownership of securities			1
09/16/22	4	Statement of changes in beneficial ownership of securities			1
08/24/22	425	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions			2
08/10/22	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Related Documents EX-FILING FEES EX-5.1 EX-23.1			13